Overview

Topical Bevacizumab for Preventing Recurrent Pterygium

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bevacizumab eye drop is effective in the treatment of recurrent pterygium.
Phase:
Phase 3
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Bevacizumab
Ophthalmic Solutions
Tetrahydrozoline